Market Overview:
The global thymosin beta-4 market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing demand for thymosin beta-4 in various applications such as skin repair, dry eye, corneal injury, myocardial injury, brain injury and others. Moreover, rising awareness about the benefits of thymosin beta-4 is also propelling the growth of this market. Based on type, the global thymosin beta-4 market has been segmented into skin repair, dry eye syndrome (DES), corneal injury and others. The skin repair segment is estimated to account for a major share of the global thymosin beta-4 market in 2018. This can be attributed to increasing use of this peptide in wound healing applications across different regions worldwide. On basis on application; human and animal segments are considered in this study .The human segment accounted for majority share of total revenue generated by application segment in 2017and it is projected that it will maintain its dominance throughout forecast period owing to growing demand from cosmetic industry coupled with rising awareness among people about benefits associated with its use .
Product Definition:
Thymosin beta-4 is a peptide that is produced by the thymus gland. It plays a role in the development of T cells, which are important for immune system function.
Skin Repair:
Skin repair is a peptide hormone that controls the wound healing process. It is produced by the body's immune system and also by fibroblasts (a type of skin cell). The main function of skin repair is to initiate and accelerate the healing process after injury or trauma has occurred. This peptide hormone also plays an important role in wound closure, which enables it to be known as a growth factor for epithelial tissue including skin, hair, and nails.
Dry Eye:
Dry eye is a common disorder affecting the eye surface that may result in decreased tear production. It is also known as Xerophthalmia and Xerostomia. The disorder can be caused due to several factors such as genetic disorders, drugs (such as anti-epileptics, antibiotics, chemotherapy), lifestyle changes (stress & smoking), infectious diseases (CMV infection or HIV) and autoimmune disorders.
Application Insights:
The human application segment held the largest share of more than 70.0% in 2017. The increasing prevalence of chronic diseases, such as cardiovascular disorders, respiratory problems, diabetes mellitus and autoimmune diseases is expected to be the key driving factor for thymosin beta-4 market growth in human applications over the forecast period.
Animal application segment was valued at USD 89.5 million in 2017 owing to high adoption rate of thymosin beta-4 products by animals due to its ability to repair tissue damage caused by injury or disease state. Increasing animal health issues across all regions are further anticipated to propel demand for thymosin beta-4 products from 2018 through 2030 ¢â‚¬â€œ 2030 thereby benefiting market growth across all regions during the study period.
Regional Analysis:
North America held the largest revenue share of the global market in 2017. The region is expected to maintain its dominance throughout the forecast period owing to increasing R&D activities and high healthcare expenditure. In addition, rising incidence of sports injuries, burn injuries, road accidents and other trauma cases are also contributing toward regional growth.
Asia Pacific is anticipated to witness lucrative growth over the coming years due to factors such as growing medical tourism industry and improving healthcare infrastructure in this region coupled with economic development. Moreover, an increase in chronic diseases leading to various organ failures will boost product demand further driving growth during the forecast period.
Growth Factors:
- Increasing research and development activities for novel applications of thymosin beta-4
- Growing demand from the sports medicine sector for thymosin beta-4 as a performance enhancer
- Rising prevalence of chronic diseases such as cancer, heart disease, and diabetes that can benefit from thymosin beta-4 therapy
- Increasing number of clinical studies evaluating the safety and efficacy of thymosin beta-4
- Growing popularity of peptide therapies as an alternative to traditional drug therapies
Scope Of The Report
Report Attributes
Report Details
Report Title
Thymosin beta-4 Market Research Report
By Type
Skin Repair, Dry Eye, Corneal Injury, Myocardial Injury, Brain Injury, Others
By Application
Human, Animal
By Companies
Bio-Techne, Merck, Phoenix Pharmaceuticals, Santa Cruz Biotechnology, Inc, Prospec-Tany Technogene Ltd, PeproTech, Shaanxi Hongbaiyi Biotech Co, Beijing Northland
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
174
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Thymosin beta-4 Market Report Segments:
The global Thymosin beta-4 market is segmented on the basis of:
Types
Skin Repair, Dry Eye, Corneal Injury, Myocardial Injury, Brain Injury, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Human, Animal
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Techne
- Merck
- Phoenix Pharmaceuticals
- Santa Cruz Biotechnology, Inc
- Prospec-Tany Technogene Ltd
- PeproTech
- Shaanxi Hongbaiyi Biotech Co
- Beijing Northland
Highlights of The Thymosin beta-4 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Skin Repair
- Dry Eye
- Corneal Injury
- Myocardial Injury
- Brain Injury
- Others
- By Application:
- Human
- Animal
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thymosin beta-4 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Thymosin beta-4 is a protein that helps to create the contractile proteins in muscles.
Some of the major players in the thymosin beta-4 market are Bio-Techne, Merck, Phoenix Pharmaceuticals, Santa Cruz Biotechnology, Inc, Prospec-Tany Technogene Ltd, PeproTech, Shaanxi Hongbaiyi Biotech Co, Beijing Northland.
The thymosin beta-4 market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Thymosin beta-4 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Thymosin beta-4 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Thymosin beta-4 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Thymosin beta-4 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Thymosin beta-4 Market Size & Forecast, 2020-2028
4.5.1 Thymosin beta-4 Market Size and Y-o-Y Growth
4.5.2 Thymosin beta-4 Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Skin Repair
5.2.2 Dry Eye
5.2.3 Corneal Injury
5.2.4 Myocardial Injury
5.2.5 Brain Injury
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Human
6.2.2 Animal
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Thymosin beta-4 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Thymosin beta-4 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Skin Repair
9.6.2 Dry Eye
9.6.3 Corneal Injury
9.6.4 Myocardial Injury
9.6.5 Brain Injury
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Human
9.10.2 Animal
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Skin Repair
10.6.2 Dry Eye
10.6.3 Corneal Injury
10.6.4 Myocardial Injury
10.6.5 Brain Injury
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Human
10.10.2 Animal
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Skin Repair
11.6.2 Dry Eye
11.6.3 Corneal Injury
11.6.4 Myocardial Injury
11.6.5 Brain Injury
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Human
11.10.2 Animal
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Skin Repair
12.6.2 Dry Eye
12.6.3 Corneal Injury
12.6.4 Myocardial Injury
12.6.5 Brain Injury
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Human
12.10.2 Animal
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Skin Repair
13.6.2 Dry Eye
13.6.3 Corneal Injury
13.6.4 Myocardial Injury
13.6.5 Brain Injury
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Human
13.10.2 Animal
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Thymosin beta-4 Market: Competitive Dashboard
14.2 Global Thymosin beta-4 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Techne
14.3.2 Merck
14.3.3 Phoenix Pharmaceuticals
14.3.4 Santa Cruz Biotechnology, Inc
14.3.5 Prospec-Tany Technogene Ltd
14.3.6 PeproTech
14.3.7 Shaanxi Hongbaiyi Biotech Co
14.3.8 Beijing Northland
